Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Genetic Disorders Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Genetic Disorders Drugmarket, defines the market attractiveness level of Genetic Disorders Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Genetic Disorders Drug industry, describes the types of Genetic Disorders Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Genetic Disorders Drug market and the development prospects and opportunities of Genetic Disorders Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Genetic Disorders Drug market in Chapter 13.
By Player:
Shire
Vertex
Pfizer
Amgen
BioMarin
Sarepta
Sanofi
GW Pharmaceuticals
By Type:
Cystic Fibrosis (CF)
Duchenne Muscular Dystrophy (DMD)
Lysosomal Storage Disease (LSD)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
By End-User:
Clinic
Hospital
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Genetic Disorders Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Genetic Disorders Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Genetic Disorders Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Genetic Disorders Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Genetic Disorders Drug Market Analysis and Outlook to 2022
-
7.1 Global Genetic Disorders Drug Consumption (2017-2022)
-
7.2 United States Genetic Disorders Drug Consumption (2017-2022)
-
7.3 Europe Genetic Disorders Drug Consumption (2017-2022)
-
7.4 China Genetic Disorders Drug Consumption (2017-2022)
-
7.5 Japan Genetic Disorders Drug Consumption (2017-2022)
-
7.6 India Genetic Disorders Drug Consumption (2017-2022)
-
7.7 South Korea Genetic Disorders Drug Consumption (2017-2022)
8 Region and Country-wise Genetic Disorders Drug Market Analysis and Outlook to 2028
-
8.1 Global Genetic Disorders Drug Consumption Forecast (2022-2028)
-
8.2 United States Genetic Disorders Drug Consumption Forecast (2022-2028)
-
8.3 Europe Genetic Disorders Drug Consumption Forecast (2022-2028)
-
8.4 China Genetic Disorders Drug Consumption Forecast (2022-2028)
-
8.5 Japan Genetic Disorders Drug Consumption Forecast (2022-2028)
-
8.6 India Genetic Disorders Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Genetic Disorders Drug Consumption Forecast (2022-2028)
9 Global Genetic Disorders Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Genetic Disorders Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cystic Fibrosis (CF) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Duchenne Muscular Dystrophy (DMD) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Consumption and Growth Rate (2017-2022)
-
9.2 Global Genetic Disorders Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
10 Global Genetic Disorders Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Genetic Disorders Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cystic Fibrosis (CF) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Duchenne Muscular Dystrophy (DMD) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Genetic Disorders Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
11 Global Genetic Disorders Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Genetic Disorders Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Genetic Disorders Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Genetic Disorders Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Genetic Disorders Drug Market Competitive Analysis
-
14.1 Shire
-
14.1.1 Shire Company Details
-
14.1.2 Shire Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shire Genetic Disorders Drug Product and Service
-
14.2 Vertex
-
14.2.1 Vertex Company Details
-
14.2.2 Vertex Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Vertex Genetic Disorders Drug Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Genetic Disorders Drug Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Genetic Disorders Drug Product and Service
-
14.5 BioMarin
-
14.5.1 BioMarin Company Details
-
14.5.2 BioMarin Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BioMarin Genetic Disorders Drug Product and Service
-
14.6 Sarepta
-
14.6.1 Sarepta Company Details
-
14.6.2 Sarepta Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sarepta Genetic Disorders Drug Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Genetic Disorders Drug Product and Service
-
14.8 GW Pharmaceuticals
-
14.8.1 GW Pharmaceuticals Company Details
-
14.8.2 GW Pharmaceuticals Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GW Pharmaceuticals Genetic Disorders Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Genetic Disorders Drug
-
Figure Genetic Disorders Drug Picture
-
Table Global Genetic Disorders Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Genetic Disorders Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Genetic Disorders Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Genetic Disorders Drug Consumption by Country (2017-2022)
-
Figure United States Genetic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Genetic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure China Genetic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Genetic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure India Genetic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Genetic Disorders Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Disorders Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Genetic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Genetic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Genetic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Genetic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Genetic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Genetic Disorders Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cystic Fibrosis (CF) Consumption and Growth Rate (2017-2022)
-
Figure Global Duchenne Muscular Dystrophy (DMD) Consumption and Growth Rate (2017-2022)
-
Figure Global Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)
-
Figure Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Cystic Fibrosis (CF) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Duchenne Muscular Dystrophy (DMD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Genetic Disorders Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Genetic Disorders Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Genetic Disorders Drug Product and Service
-
Table Vertex (Foundation Year, Company Profile and etc.)
-
Table Vertex Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Genetic Disorders Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Genetic Disorders Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Genetic Disorders Drug Product and Service
-
Table BioMarin (Foundation Year, Company Profile and etc.)
-
Table BioMarin Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarin Genetic Disorders Drug Product and Service
-
Table Sarepta (Foundation Year, Company Profile and etc.)
-
Table Sarepta Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sarepta Genetic Disorders Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Genetic Disorders Drug Product and Service
-
Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table GW Pharmaceuticals Genetic Disorders Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GW Pharmaceuticals Genetic Disorders Drug Product and Service
-
